Collagens in primary frozen shoulder: expression of collagen mRNA isoforms in the different phases of the disease.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
02 08 2021
Historique:
received: 23 03 2020
revised: 24 09 2020
pubmed: 22 12 2020
medline: 24 8 2021
entrez: 21 12 2020
Statut: ppublish

Résumé

Primary frozen shoulder (pFS) has three phases that differ in clinical presentation. It is characterized by contracture of the joint capsule. We hypothesized that there is a general upregulation of collagens in pFS, and that this is highest in the first phase of the disease. The aims of this study were to investigate the expression of various collagens and degradation of collagens in patients with primary pFS and relate this to the three phases of the condition. From twenty-six patients with pFS and eight control patients with subacromial impingement, biopsies were obtained during shoulder arthroscopy from the middle glenohumeral ligament and the anterior capsule, and mRNA levels for collagens, MMP-2 and -14 and TGF-β1, - β2 and -β3 in the tissue were analysed using real-time PCR. Genes for collagens type I, III, IV, V, VI and XIV, were activated in pFS, and the total mRNA for all collagens was increased (P < 0.05). This upregulation was independent of disease phases in pFS. In addition, MMP-2, MMP-14, TGF-β1 and TGF-β3 were upregulated in all phases of the disease. There is a general upregulation and an increased degradation of collagens in pFS in all three phases of the disease. This indicates a constantly increased turnover of the fibrotic tissue in the capsule from pFS. The difference in clinical presentation of pFS observed in the three phases of the disease is not primarily a result of variations in collagen production.

Identifiants

pubmed: 33347577
pii: 6043114
doi: 10.1093/rheumatology/keaa802
doi:

Substances chimiques

Collagen Type I 0
Collagen Type III 0
Collagen Type IV 0
Collagen Type V 0
Collagen Type VI 0
RNA, Messenger 0
TGFB1 protein, human 0
TGFB2 protein, human 0
TGFB3 protein, human 0
Transforming Growth Factor beta1 0
Transforming Growth Factor beta2 0
Transforming Growth Factor beta3 0
Collagen 9007-34-5
MMP2 protein, human EC 3.4.24.24
Matrix Metalloproteinase 2 EC 3.4.24.24
MMP14 protein, human EC 3.4.24.80
Matrix Metalloproteinase 14 EC 3.4.24.80

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3879-3887

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Line Marker (L)

Section for Sports Traumatology M51, Department of Orthopaedic Surgery M, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.

Peter Schjerling (P)

Institute of Sports Medicine, Department of Orthopaedic Surgery M, Bispebjerg and Frederiksberg Hospital, Center for Healthy Aging, Faculty of Health and Medical Sciences, Copenhagen, Denmark.

Abigail L Mackey (AL)

Institute of Sports Medicine, Department of Orthopaedic Surgery M, Bispebjerg and Frederiksberg Hospital, Center for Healthy Aging, Faculty of Health and Medical Sciences, Copenhagen, Denmark.
Xlab, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Thomas Hansen (T)

Section for Sports Traumatology M51, Department of Orthopaedic Surgery M, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.

Jens Jakobsen (J)

Section for Sports Traumatology M51, Department of Orthopaedic Surgery M, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.

Michael Kjær (M)

Institute of Sports Medicine, Department of Orthopaedic Surgery M, Bispebjerg and Frederiksberg Hospital, Center for Healthy Aging, Faculty of Health and Medical Sciences, Copenhagen, Denmark.

Michael R Krogsgaard (MR)

Section for Sports Traumatology M51, Department of Orthopaedic Surgery M, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH